The Clinical Advantages of Combination Therapies in Advanced RCC

Videos - Interview with the Innovators
Nephrectomy is often the initial treatment for renal-cell cancer (RCC), but systemic therapy is frequently required for advanced RCC. Single-agent targeted therapies are only somewhat effective, which led to the development of immunotherapies and combination therapies (which include immunotherapies). Laura Wood, RN, MSN, OCN, and Virginia Seery, MSN, RN, ANP-BC, AOCNP, discuss the clinical advantages of combination therapies in patients with advanced RCC.
Related Items
The Multidisciplinary Care Approach to Cancer Care Management
Megan Price, MSN, APRN, FNP-C, Virginia Seery, MSN, RN, ANP-BC, AOCNP, Laura Wood, RN, MSN, OCN
Videos published on June 2, 2021 in Interview with the Innovators
Improving the Patient Experience by Helping Patients Navigate Their Cancer Care
Megan Price, MSN, APRN, FNP-C, Virginia Seery, MSN, RN, ANP-BC, AOCNP, Laura Wood, RN, MSN, OCN
Videos published on May 7, 2021 in Interview with the Innovators
Copyright © Green Hill Healthcare Communications, LLC. All rights reserved.